{"gene":"MAPK8","run_date":"2026-06-10T02:59:50","timeline":{"discoveries":[{"year":1999,"finding":"GSTp (glutathione S-transferase Pi) was purified and identified as a JNK-associated inhibitor protein. Monomeric GSTp inhibits JNK activity in a dose-dependent manner; UV irradiation or H2O2 treatment causes GSTp oligomerization and dissociation of the GSTp-JNK complex, relieving inhibition. GSTp inhibition of JNK is independent of the MEKK1-MKK4 module.","method":"Protein purification, co-immunoprecipitation, in vitro kinase assay with purified GSTp, immunodepletion, forced expression/cDNA complementation in GSTp-null MEFs","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple orthogonal methods (purification, Co-IP, in vitro activity assay, genetic knockout MEFs, siRNA/inhibitor studies) in a single rigorous study with strong mechanistic follow-up","pmids":["10064598"],"is_preprint":false},{"year":1998,"finding":"MKK4 and MKK7 synergistically activate SAPK1/JNK1 in vitro: MKK4 preferentially phosphorylates the tyrosine residue (Tyr-185) and MKK7 preferentially phosphorylates the threonine residue (Thr-183) within the Thr-Pro-Tyr activation motif, such that both kinases together produce synergistic activation.","method":"In vitro kinase assay, site-specific phosphorylation analysis","journal":"Current biology : CB","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with site-specific phosphorylation mapping, replicated in a subsequent independent study (PMID 11062067)","pmids":["9889102","11062067"],"is_preprint":false},{"year":2000,"finding":"MKK4 shows striking preference for phosphorylation of Tyr-185, and MKK7 shows striking preference for Thr-183 in JNK1α1, JNK2α2, and JNK3α1 isoforms, producing synergistic activation when combined. MKK7 also phosphorylates JNK2α2 at Thr-404 and Ser-407 in vitro and in cells.","method":"In vitro kinase assay with three SAPK1/JNK isoforms, phospho-specific immunoblotting in KB cells and HEK-293 cells","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with site-specific mutagenesis/mapping across multiple isoforms, corroborated by cell-based phosphorylation studies","pmids":["11062067"],"is_preprint":false},{"year":2003,"finding":"JNK1 phosphorylates paxillin at Ser178 both in vitro and in intact cells. Expression of the Ser178→Ala paxillin mutant inhibited rapid cell migration in fish keratocytes and NBT-II cells, blocking the labile adhesions required for rapid movement.","method":"In vitro kinase assay, site-directed mutagenesis, single-cell migration and wound-healing assays","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro phosphorylation assay with mutagenesis validation, functional phenotype confirmed in multiple cell types across two migration assay formats","pmids":["12853963"],"is_preprint":false},{"year":2003,"finding":"JNK phosphorylates BIM(EL) at Ser65, potentiating its proapoptotic activity. Mitochondrially localized JNK specifically phosphorylates BIM(EL), whereas upstream activators (MLKs, MKKs) do not. This phosphorylation both promotes BIM(EL) expression transcriptionally and increases its proapoptotic activity posttranslationally.","method":"In vitro kinase assay, site-directed mutagenesis (Ser65), subcellular fractionation, loss-of-function JNK pathway inhibition with functional apoptosis readouts","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — in vitro phosphorylation with mutagenesis, mitochondrial localization established by fractionation, complementary gain/loss-of-function experiments","pmids":["12818176"],"is_preprint":false},{"year":2005,"finding":"RACK1 serves as an adaptor for PKC-mediated JNK activation. PKC phosphorylates JNK on Ser129 in a RACK1-dependent manner; Ser129 phosphorylation augments subsequent JNK phosphorylation by MKK4/MKK7 and is required for JNK activation by TPA, TNFα, UV irradiation, and PKC, but not by anisomycin or MEKK1.","method":"Co-immunoprecipitation, site-directed mutagenesis (Ser129), siRNA knockdown of RACK1, in vitro kinase assay","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — Co-IP, site-specific mutagenesis, and siRNA knockdown with multiple stimuli and functional readouts in single study","pmids":["16061178"],"is_preprint":false},{"year":2006,"finding":"JNK1 phosphorylates SCG10 (a stathmin-family microtubule-destabilizing protein) in vivo at Ser62 and Ser73, regulating its microtubule-depolymerizing activity. SCG10-S73 phosphorylation is significantly decreased in JNK1-/- cortex. JNK1 phosphorylation of SCG10 determines axodendritic length in cerebrocortical cultures.","method":"Affinity purification of JNK-interacting proteins from brain, in vivo phosphorylation with phospho-site mapping, JNK1-/- mouse cortex analysis, FRAP (fluorescent tubulin recovery), neurite length assays","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — in vivo phosphorylation validated in knockout mice, multiple orthogonal methods including FRAP and neurite assays","pmids":["16618812"],"is_preprint":false},{"year":2009,"finding":"JNK1 physically interacts with SIRT1 under oxidative stress conditions (co-immunoprecipitation of endogenous proteins). JNK1 phosphorylates SIRT1 at Ser27, Ser47, and Thr530, increasing SIRT1 nuclear localization and enzymatic activity with substrate specificity: phosphorylated SIRT1 deacetylates histone H3 but not p53.","method":"Co-immunoprecipitation of endogenous proteins, in vitro kinase assay, site-directed mutagenesis, nuclear fractionation, SIRT1 enzymatic activity assay, RNAi","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — endogenous Co-IP, in vitro phosphorylation with site mapping, functional enzymatic activity measurements, single lab with multiple orthogonal methods","pmids":["20027304"],"is_preprint":false},{"year":2010,"finding":"Nuclear-localized JNK is degraded by the APC/C(Cdh1) ubiquitin ligase during exit from mitosis and G1 phase. Conversely, JNK phosphorylates Cdh1 during G2 and early mitosis, changing Cdh1 subcellular localization and attenuating its ability to activate the APC/C during G2/M.","method":"Co-immunoprecipitation, subcellular fractionation, in vitro kinase assay, expression of non-degradable JNK mutant, cell cycle synchronization","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — reciprocal regulation demonstrated by multiple methods including in vitro phosphorylation, non-degradable mutant overexpression, and APC/C activity assays","pmids":["20581839"],"is_preprint":false},{"year":1996,"finding":"HPK1 (hematopoietic progenitor kinase 1) specifically activates the SAPK/JNK pathway after transfection, acting via the SH3-containing mixed lineage kinase MLK-3 and the known SAPK activator SEK1 (MKK4). HPK1 does not stimulate p38/RK or ERK pathways.","method":"Transfection into COS1 cells, pathway-specific kinase activity assays, epistasis with dominant-negative pathway components","journal":"The EMBO journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis in cell-based system with pathway specificity controls, single lab","pmids":["9003777"],"is_preprint":false},{"year":2001,"finding":"Protein kinase G (PKG) activates JNK1 through a PKG-MEKK1-SEK1-JNK1 pathway by directly phosphorylating MEKK1. A dominant-negative MEKK1 inhibited PKG-induced JNK1 activation and c-Jun transactivation. In vitro assays showed purified PKG directly phosphorylated the N-terminal domain of MEKK1.","method":"In vitro kinase assay with purified PKG and MEKK1, constitutively active PKG mutant expression, dominant-negative MEKK1 epistasis, AP-1 reporter assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1-2 / Moderate — in vitro kinase reconstitution with epistasis, single lab with multiple complementary methods","pmids":["11278263"],"is_preprint":false},{"year":2003,"finding":"Glucocorticoid receptor (GR) inhibits JNK activation by physically associating with JNK upon glucocorticoid treatment, promoting disassembly of JNK from MKK7. A hormone-regulated JNK docking site was characterized in the GR ligand-binding domain. GC-induced GR-JNK association correlates with increased loading of inactive JNK on AP-1-bound response elements of the c-jun gene.","method":"Co-immunoprecipitation, domain mapping mutagenesis, chromatin immunoprecipitation (ChIP), inactive JNK nuclear transfer assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — Co-IP with domain mutagenesis, ChIP validation, and mechanistic dissection of GR-JNK interaction with multiple functional readouts","pmids":["14609950"],"is_preprint":false},{"year":1998,"finding":"JNK1 signaling is required for T cell receptor-initiated TH cell proliferation, apoptosis, and differentiation. Jnk1-/- T cells hyperproliferate, show decreased activation-induced cell death, and preferentially differentiate to TH2 cells. Enhanced TH2 cytokine production is associated with increased nuclear accumulation of NFATc.","method":"Jnk1 knockout mouse analysis, T cell activation assays, cytokine profiling, NFATc nuclear localization assay","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic loss-of-function with defined cellular phenotypes across multiple readouts (proliferation, apoptosis, differentiation, transcription factor localization)","pmids":["9851932"],"is_preprint":false},{"year":1999,"finding":"Jnk1 and Jnk2 are jointly required for region-specific apoptosis during early brain development. Jnk1/Jnk2 double-knockout compound mutants are embryonic lethal with severe dysregulation of apoptosis: reduced cell death in lateral hindbrain and increased apoptosis/caspase activation in forebrain.","method":"Jnk1-/-, Jnk2-/-, Jnk3-/- single and compound knockout mice, histological analysis, caspase activation assays","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic loss-of-function in vivo with defined region-specific apoptotic phenotypes and caspase activation measurements","pmids":["10230788"],"is_preprint":false},{"year":2007,"finding":"JNK1-dependent PUMA expression contributes to hepatocyte lipoapoptosis. Palmitate induction of PUMA is JNK1-dependent in primary murine hepatocytes; phosphorylated c-Jun in an AP-1 complex directly binds the PUMA promoter as shown by EMSA and ChIP. PUMA knockdown attenuated Bax activation, caspase 3/7 activity, and cell death.","method":"JNK1 knockout primary hepatocytes, dominant-negative c-Jun, EMSA, chromatin immunoprecipitation (ChIP), shRNA knockdown, caspase activity assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — genetic knockout, ChIP, EMSA, and shRNA with multiple functional readouts in a single mechanistic study","pmids":["19638343"],"is_preprint":false},{"year":2009,"finding":"Hepatic JNK1 prevents steatosis: mice with specific ablation of Jnk1 in hepatocytes develop glucose intolerance, insulin resistance, and hepatic steatosis, demonstrating that JNK1 serves opposing actions in liver versus adipose tissue.","method":"Hepatocyte-specific Jnk1 conditional knockout mice, glucose tolerance tests, insulin sensitivity assays, histological analysis of liver","journal":"Cell metabolism","confidence":"High","confidence_rationale":"Tier 2 / Strong — tissue-specific conditional knockout with defined metabolic phenotypes, multiple physiological readouts","pmids":["19945406"],"is_preprint":false},{"year":2009,"finding":"JNK2-deficient mice on high-fat diet show increased liver injury through a Bim-dependent activation of the mitochondrial death pathway. JNK2 ablation increases hepatic expression of proapoptotic Bcl-2 family members Bim and Bax, revealing that JNK1 and JNK2 have distinct isoform-specific effects on steatohepatitis.","method":"Jnk1-/- and Jnk2-/- knockout mice, antisense oligonucleotide knockdown, high-fat diet model, Western blot for apoptotic proteins, histological analysis","journal":"Hepatology","confidence":"High","confidence_rationale":"Tier 2 / Strong — isoform-specific genetic knockouts with molecular pathway characterization across multiple readouts","pmids":["19053047"],"is_preprint":false},{"year":2022,"finding":"JNK1/2 phosphorylates BNIP3 at Ser60/Thr66 under hypoxia, which hampers proteasomal degradation of BNIP3 and promotes mitophagy by facilitating direct binding of BNIP3 to LC3. PP1/2A dephosphorylates BNIP3 and triggers its proteasomal degradation, suppressing mitophagy.","method":"In vitro kinase assay, site-directed mutagenesis, co-immunoprecipitation (BNIP3-LC3), proteasome inhibitor assays, mitophagy readouts under hypoxia","journal":"Cell death & disease","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — in vitro phosphorylation with site mutagenesis, Co-IP for BNIP3-LC3 interaction, and functional mitophagy assays, single lab","pmids":["36396625"],"is_preprint":false},{"year":2007,"finding":"FDH-induced p53 phosphorylation at Ser6 is carried out by JNK1 and JNK2 cooperatively: JNK1 phosphorylates JNK2 first, and then JNK2 (but not JNK1) directly phosphorylates p53 at Ser6. Pull-down assay showed JNK2 but not JNK1 physically associates with p53.","method":"siRNA knockdown of JNK1 and JNK2, pharmacological inhibitor SP600125, pull-down assay, phospho-specific Western blot","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — pull-down and siRNA with phospho-site readout, two isoforms distinguished, single lab","pmids":["17525747"],"is_preprint":false},{"year":2010,"finding":"JNK1 is required for platelet secretion and thrombus formation in vivo. JNK1-/- platelets show impaired secretion at low agonist doses, leading to altered integrin αIIbβ3 activation and reduced platelet aggregation via a mechanism involving protein kinase C. In vivo, JNK1-/- mice show prolonged bleeding times and reduced thrombus formation.","method":"JNK1-/- knockout mice, tail-bleeding assay, whole-blood perfusion on collagen matrix, in vivo photochemical thrombosis model, in vitro platelet aggregation and secretion assays","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic loss-of-function with multiple in vitro and in vivo functional assays, PKC pathway involvement identified","pmids":["20231429"],"is_preprint":false},{"year":2017,"finding":"JNK1 suppresses antifungal immunity by inhibiting CD23 expression through NFATc1-mediated regulation of the CD23 gene promoter. JNK1 deficiency leads to higher CD23 induction, and CD23-dependent nitric oxide production mediates the enhanced antifungal response.","method":"JNK1-/- mice, bone marrow chimeras, CD23 promoter reporter assays, NFATc1 knockdown, nitric oxide measurement, pharmacological JNK inhibition","journal":"Nature medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout with bone marrow chimeras, promoter reporter assays, and mechanistic rescue experiments","pmids":["28112734"],"is_preprint":false},{"year":2023,"finding":"USP14 is a deubiquitinase that physically interacts with JNK and stabilizes it by removing ubiquitin modifications, thereby sustaining MAPK/JNK signaling. USP14 ablation reduces JNK protein levels and downstream pathway activation.","method":"Co-immunoprecipitation, RNA-seq, luciferase reporter assay, USP14 knockdown/knockout in vitro and in vivo, Western blot for ubiquitination","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — Co-IP and loss-of-function with pathway readout, single lab, ubiquitination mechanism inferred but deubiquitination assay details limited in abstract","pmids":["36693850"],"is_preprint":false},{"year":2012,"finding":"TRAF2- and RIPK1-mediated MAPK8/JNK activation is required for TNFSF10/TRAIL-induced cytoprotective autophagy. MAPK8 activation mediates BCL2L1/Bcl-xL degradation and dissolution of the BCL2L1-BECN1 complex. Knockdown of TRAF2 or RIPK1 suppresses TNFSF10-induced MAPK8 activation and autophagy.","method":"siRNA knockdown of TRAF2, RIPK1, BECN1, ATG7; pharmacological inhibitors; apoptosis and autophagy assays in multiple cancer cell lines","journal":"Autophagy","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — multiple siRNA targets with functional autophagy/apoptosis readouts, pathway ordering established, single lab","pmids":["23051914"],"is_preprint":false},{"year":2019,"finding":"JNK1 regulates RANKL-induced osteoclastogenesis via a Bcl-2-Beclin1-autophagy pathway: RANKL induces JNK1-dependent phosphorylation of Bcl-2, which dissociates Beclin1 from the Bcl-2-Beclin1 complex to activate autophagy. JNK1 inhibition blocks this dissociation and increases apoptosis; Beclin1 overexpression rescues autophagy deficiency caused by JNK inhibition.","method":"Pharmacological JNK inhibitor (SP600125), RNA interference, Beclin1 overexpression rescue, Western blot for Bcl-2 phosphorylation, co-immunoprecipitation of Bcl-2-Beclin1 complex, autophagy and apoptosis assays","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — Co-IP, phosphorylation analysis, and rescue experiments, single lab with multiple complementary methods","pmids":["31295022"],"is_preprint":false},{"year":2012,"finding":"JNK1 inhibits GluR1 expression by phosphorylating Hes-1 at Ser263, stabilizing Hes-1 protein. Stabilized Hes-1 suppresses GluR1 promoter activity via N-box binding and by preventing Mash1/E47 from binding the E-box, ultimately inhibiting AMPA-evoked calcium influx in cortical neurons.","method":"In vitro kinase assay, site-directed mutagenesis (Ser263), promoter-reporter assay, chromatin immunoprecipitation, calcium imaging in cortical neurons","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — in vitro phosphorylation with site mutagenesis, ChIP, promoter reporter, and functional calcium influx assay, single lab with multiple orthogonal methods","pmids":["22302822"],"is_preprint":false},{"year":2009,"finding":"JNK1 determines whether integrin-linked kinase (ILK) functions as an oncogene or tumor suppressor in rhabdomyosarcoma. In ARMS cells, ILK depletion reduces JNK1/c-Jun signaling and suppresses growth; in ERMS cells, ILK depletion activates JNK1/c-Jun, promoting growth. Restoration of JNK1 in ARMS reestablishes a tumor-suppressive ILK function.","method":"RNAi-mediated ILK depletion, JNK1 restoration experiments, in vitro and in vivo growth assays, PAX3-FKHR expression in ERMS cells","journal":"The Journal of clinical investigation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic manipulation with in vitro and in vivo functional readouts, JNK1 identified as non-canonical ILK effector, single lab","pmids":["19478459"],"is_preprint":false},{"year":2018,"finding":"JNK pathway deficiency causes genomic instability and breast cancer development in mice. Loss of JNK signaling in breast epithelium leads to widespread early neoplasia and rapid tumor formation, identifying JNK as a tumor suppressor that prevents tumor initiation rather than controlling established tumor growth.","method":"Mammary epithelium-specific JNK knockout mice, breast cancer mouse model, genomic instability assays, tumor incidence and histological analysis","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 / Strong — tissue-specific genetic knockout with defined mechanistic distinction between tumor initiation and growth suppression functions","pmids":["29856313"],"is_preprint":false},{"year":2004,"finding":"Sef physically interacts with TAK1 and activates JNK through a TAK1-MKK4-JNK pathway. Dominant-negative forms of MKK4 and TAK1 blocked Sef-mediated JNK activation and attendant apoptosis.","method":"Co-immunoprecipitation, dominant-negative epistasis constructs (MKK4-DN, TAK1-DN), apoptosis assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — Co-IP and genetic epistasis with functional apoptosis readout, single lab","pmids":["15277532"],"is_preprint":false},{"year":2008,"finding":"Active (phosphorylated) MAPK8 colocalizes with BMF in testicular germ cells upon detachment from Sertoli cells; p-MAPK8 levels increase in round spermatids and spermatocytes undergoing apoptosis after Sertoli cell removal, suggesting MAPK8 activation and BMF redistribution mediate anoikis-like apoptosis of germ cells.","method":"Immunohistochemistry, Western blot for p-MAPK8/total MAPK8, immunocytochemistry of isolated germ cells in culture","journal":"Journal of andrology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — correlative co-localization and Western blot data, no direct causal experimental manipulation of MAPK8","pmids":["18222916"],"is_preprint":false}],"current_model":"MAPK8/JNK1 is a stress-activated serine/threonine kinase that is dually phosphorylated on Thr183 (by MKK7) and Tyr185 (by MKK4) for full activation; it phosphorylates a broad array of substrates including transcription factors (c-Jun at Ser63/Ser73), cytoskeletal regulators (paxillin at Ser178, SCG10 at Ser62/Ser73), apoptotic mediators (BIM(EL) at Ser65, BNIP3 at Ser60/Thr66), and other signaling molecules (SIRT1 at Ser27/Ser47/Thr530, Hes-1 at Ser263, Cdh1, Bcl-2); its activity is regulated by scaffold/inhibitor proteins (GSTp, RACK1), by upstream kinases including PKC via RACK1-Ser129 phosphorylation, and by the deubiquitinase USP14 which stabilizes JNK protein; cell-type-specific and isoform-specific functions include roles in T cell differentiation, platelet secretion, hepatic lipid metabolism, antifungal immunity, neuronal cytoarchitecture, cell migration, osteoclastogenesis, and tumor suppression via genome stability maintenance."},"narrative":{"mechanistic_narrative":"MAPK8/JNK1 is a stress-activated serine/threonine kinase that integrates diverse upstream signals into the phosphorylation of substrates governing apoptosis, transcription, cytoskeletal dynamics, cell-cycle progression, and tissue-specific physiology [PMID:9889102, PMID:11062067, PMID:12818176]. Full activation requires dual phosphorylation of its Thr-Pro-Tyr activation motif, with MKK4 preferentially modifying Tyr-185 and MKK7 preferentially modifying Thr-183, so that the two upstream kinases act synergistically across JNK isoforms [PMID:9889102, PMID:11062067]. The kinase is fed by multiple upstream modules — HPK1 acting through MLK-3 and MKK4 [PMID:9003777], PKG via direct MEKK1 phosphorylation [PMID:11278263], Sef through a TAK1–MKK4 route [PMID:15277532], and PKC acting through the RACK1 adaptor to phosphorylate JNK on Ser129, which primes subsequent MKK4/MKK7 activation [PMID:16061178]. JNK activity is restrained by the inhibitor GSTp, which dissociates upon oxidative stress to relieve inhibition [PMID:10064598], by glucocorticoid receptor binding that displaces JNK from MKK7 [PMID:14609950], and is sustained at the protein level by the deubiquitinase USP14 [PMID:36693850]. Among its effectors, JNK phosphorylates the transcription factor axis and apoptotic machinery, including BIM(EL) at Ser65 to potentiate proapoptotic activity [PMID:12818176], BNIP3 at Ser60/Thr66 to license LC3-dependent mitophagy [PMID:36396625], Bcl-2 to release Beclin1 and drive autophagy [PMID:31295022], SIRT1 at Ser27/Ser47/Thr530 to enhance its nuclear deacetylase activity [PMID:20027304], Hes-1 at Ser263 to repress GluR1 transcription in neurons [PMID:22302822], the cytoskeletal regulators paxillin at Ser178 for rapid cell migration [PMID:12853963] and SCG10 at Ser62/Ser73 to control axodendritic length [PMID:16618812], and the cell-cycle regulator Cdh1, establishing reciprocal control with the APC/C that also degrades nuclear JNK [PMID:20581839]. At the organismal level, JNK1 directs TH cell proliferation, apoptosis, and TH2 differentiation [PMID:9851932], guides region-specific apoptosis in brain development [PMID:10230788], protects against hepatic steatosis [PMID:19945406], drives hepatocyte lipoapoptosis through PUMA induction [PMID:19638343], supports platelet secretion and thrombus formation [PMID:20231429], and restrains antifungal immunity via NFATc1-dependent CD23 suppression [PMID:28112734]. Loss of JNK signaling in breast epithelium produces genomic instability and tumor initiation, defining JNK as a tumor suppressor [PMID:29856313].","teleology":[{"year":1996,"claim":"Identifying HPK1 as a selective upstream activator established that JNK is engaged through a defined MLK-3/MKK4 kinase cascade distinct from the ERK and p38 pathways.","evidence":"Transfection in COS1 cells with pathway-specific kinase assays and dominant-negative epistasis","pmids":["9003777"],"confidence":"Medium","gaps":["Physiological stimuli engaging HPK1 to JNK not defined","Single cell-based overexpression system"]},{"year":1998,"claim":"Mapping the dual-specificity input resolved how JNK reaches full activity: MKK4 and MKK7 phosphorylate distinct residues of the activation loop and act synergistically.","evidence":"In vitro kinase assays with site-specific phosphorylation mapping, extended across JNK isoforms","pmids":["9889102","11062067"],"confidence":"High","gaps":["In vivo stoichiometry of dual phosphorylation not addressed","Functional consequence of MKK7-mediated Thr-404/Ser-407 phosphorylation unclear"]},{"year":1998,"claim":"Jnk1 knockout T cells defined a physiological role in adaptive immunity, showing JNK1 restrains proliferation and biases TH differentiation toward TH2.","evidence":"Jnk1-/- mouse T cell activation, cytokine profiling, and NFATc localization assays","pmids":["9851932"],"confidence":"High","gaps":["Direct JNK1 substrates controlling NFATc accumulation not identified","Isoform redundancy with JNK2 not resolved"]},{"year":1999,"claim":"Discovery of GSTp as a dissociable inhibitor established a redox-gated brake on JNK independent of the MEKK1-MKK4 module.","evidence":"Protein purification, Co-IP, in vitro kinase assays, and GSTp-null MEF complementation","pmids":["10064598"],"confidence":"High","gaps":["Structural basis of GSTp oligomerization-driven release not defined"]},{"year":1999,"claim":"Compound knockouts showed JNK1 and JNK2 jointly govern region-specific apoptosis essential for brain morphogenesis.","evidence":"Single and compound Jnk knockout mice with histology and caspase activation assays","pmids":["10230788"],"confidence":"High","gaps":["Effector substrates mediating region-specific death not identified","Mechanism of opposing forebrain vs hindbrain effects unknown"]},{"year":2003,"claim":"Substrate-level studies connected JNK to cell migration and apoptosis: phosphorylation of paxillin Ser178 enables labile adhesions, and BIM(EL) Ser65 phosphorylation potentiates the mitochondrial death pathway.","evidence":"In vitro kinase assays, site mutagenesis, migration assays, and subcellular fractionation","pmids":["12853963","12818176"],"confidence":"High","gaps":["Spatial control of mitochondrial vs cytoskeletal JNK pools not fully resolved"]},{"year":2003,"claim":"Glucocorticoid receptor binding was shown to inhibit JNK by displacing it from MKK7, defining a hormone-regulated docking mechanism that loads inactive JNK onto AP-1 elements.","evidence":"Co-IP, domain mapping, ChIP, and inactive-JNK nuclear transfer assays","pmids":["14609950"],"confidence":"High","gaps":["Generality of inactive-JNK promoter loading across genes not established"]},{"year":2005,"claim":"Identification of RACK1-dependent PKC phosphorylation of JNK Ser129 revealed a priming step required for activation by specific stimuli.","evidence":"Co-IP, Ser129 mutagenesis, RACK1 siRNA, and in vitro kinase assays across multiple stimuli","pmids":["16061178"],"confidence":"High","gaps":["Structural mechanism by which Ser129 priming augments MKK activation unknown"]},{"year":2006,"claim":"In vivo identification of SCG10 as a JNK1 substrate linked the kinase to neuronal microtubule dynamics and axodendritic architecture.","evidence":"Affinity purification, in vivo phospho-site mapping, JNK1-/- cortex analysis, FRAP, and neurite assays","pmids":["16618812"],"confidence":"High","gaps":["Contribution relative to other stathmin-family regulators not quantified"]},{"year":2009,"claim":"JNK1 was shown to physically engage and phosphorylate SIRT1 under oxidative stress, enhancing its nuclear localization and substrate-selective deacetylase activity.","evidence":"Endogenous Co-IP, in vitro kinase with site mapping, nuclear fractionation, and deacetylase assays","pmids":["20027304"],"confidence":"High","gaps":["Basis for SIRT1 substrate switching (H3 vs p53) not mechanistically defined"]},{"year":2009,"claim":"Tissue-specific and isoform-specific knockouts revealed opposing roles in liver: hepatic JNK1 protects against steatosis while driving lipoapoptosis via PUMA, and JNK2 restrains Bim/Bax-dependent injury.","evidence":"Hepatocyte-specific and global Jnk knockouts, ChIP/EMSA, antisense knockdown, and metabolic readouts","pmids":["19945406","19638343","19053047"],"confidence":"High","gaps":["Reconciliation of protective vs proapoptotic hepatic JNK1 roles incomplete","Cell-type origin of opposing effects not fully delineated"]},{"year":2010,"claim":"Reciprocal regulation between JNK and APC/C(Cdh1) was established: APC/C degrades nuclear JNK during mitotic exit while JNK phosphorylates Cdh1 to attenuate APC/C in G2/M, integrating JNK into cell-cycle control.","evidence":"Co-IP, fractionation, in vitro kinase, non-degradable JNK mutant, and synchronization assays","pmids":["20581839"],"confidence":"High","gaps":["Cell-cycle phenotype of preventing JNK degradation not fully characterized"]},{"year":2010,"claim":"Jnk1 knockout established a role in hemostasis, with JNK1 required for platelet secretion, integrin activation, and thrombus formation via PKC.","evidence":"Jnk1-/- platelets, aggregation/secretion assays, bleeding time, and in vivo thrombosis models","pmids":["20231429"],"confidence":"High","gaps":["Platelet JNK1 substrates driving secretion not identified"]},{"year":2012,"claim":"JNK was placed in autophagy regulation downstream of TRAF2/RIPK1, mediating Bcl-xL degradation and BCL2L1-BECN1 dissolution to enable cytoprotective autophagy.","evidence":"siRNA of TRAF2/RIPK1/BECN1/ATG7 with autophagy and apoptosis readouts in cancer lines","pmids":["23051914"],"confidence":"Medium","gaps":["Direct JNK phosphorylation event triggering Bcl-xL degradation not mapped","Single-lab pathway ordering"]},{"year":2012,"claim":"Phosphorylation of Hes-1 at Ser263 defined a transcriptional mechanism by which JNK1 represses GluR1 and dampens AMPA-evoked calcium signaling in neurons.","evidence":"In vitro kinase, Ser263 mutagenesis, promoter reporter, ChIP, and calcium imaging","pmids":["22302822"],"confidence":"High","gaps":["Physiological context driving this pathway in vivo not established"]},{"year":2017,"claim":"JNK1 was shown to suppress antifungal immunity by limiting NFATc1-driven CD23 expression and CD23-dependent nitric oxide production.","evidence":"Jnk1-/- mice, bone marrow chimeras, CD23 promoter reporters, and NO measurement","pmids":["28112734"],"confidence":"High","gaps":["Direct JNK1 substrate controlling NFATc1-CD23 axis not identified"]},{"year":2018,"claim":"Mammary-specific JNK deletion defined JNK as a tumor suppressor acting through genome stability to prevent tumor initiation rather than restrain established growth.","evidence":"Mammary epithelium-specific JNK knockout mice with genomic instability and tumor incidence assays","pmids":["29856313"],"confidence":"High","gaps":["Molecular substrates linking JNK to genome stability not defined"]},{"year":2022,"claim":"JNK1/2 phosphorylation of BNIP3 at Ser60/Thr66 was shown to stabilize BNIP3 and promote LC3-dependent mitophagy under hypoxia, with PP1/2A reversing the modification.","evidence":"In vitro kinase, site mutagenesis, BNIP3-LC3 Co-IP, proteasome inhibition, and mitophagy assays","pmids":["36396625"],"confidence":"High","gaps":["Relative contribution of JNK1 vs JNK2 not separated","Single-lab study"]},{"year":2023,"claim":"USP14 was identified as a deubiquitinase that binds and stabilizes JNK protein, sustaining pathway output.","evidence":"Co-IP, knockdown/knockout in vitro and in vivo, and ubiquitination Western blots","pmids":["36693850"],"confidence":"Medium","gaps":["Direct deubiquitination of JNK not biochemically reconstituted","Specific ubiquitin chain/site removed not defined"]},{"year":null,"claim":"How JNK1 isoform- and tissue-specific outputs are encoded — the rules selecting among apoptotic, autophagic, cytoskeletal, transcriptional, and tumor-suppressive substrates in a given context — remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unifying model linking scaffold/upstream input to substrate choice","Distinct JNK1 vs JNK2 substrate repertoires incompletely defined","Spatial control of JNK substrate pools not systematically mapped"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[1,2,3,4,6,7,8,17,24]},{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[1,3,4,6,7,17,24]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[7,24]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[8,11]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[4]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[1,2,5,9,10,27]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[4,13,14,16]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[17,22,23]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[8]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[12,20]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[11,14,24]}],"complexes":[],"partners":["MKK4","MKK7","GSTP","RACK1","SIRT1","CDH1","USP14","BNIP3"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P45983","full_name":"Mitogen-activated protein kinase 8","aliases":["JNK-46","Stress-activated protein kinase 1c","SAPK1c","Stress-activated protein kinase JNK1","c-Jun N-terminal kinase 1"],"length_aa":427,"mass_kda":48.3,"function":"Serine/threonine-protein kinase involved in various processes such as cell proliferation, differentiation, migration, transformation and programmed cell death. Extracellular stimuli such as pro-inflammatory cytokines or physical stress stimulate the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway (PubMed:28943315). In this cascade, two dual specificity kinases MAP2K4/MKK4 and MAP2K7/MKK7 phosphorylate and activate MAPK8/JNK1. In turn, MAPK8/JNK1 phosphorylates a number of transcription factors, primarily components of AP-1 such as JUN, JDP2 and ATF2 and thus regulates AP-1 transcriptional activity (PubMed:18307971). Phosphorylates the replication licensing factor CDT1, inhibiting the interaction between CDT1 and the histone H4 acetylase HBO1 to replication origins (PubMed:21856198). Loss of this interaction abrogates the acetylation required for replication initiation (PubMed:21856198). Promotes stressed cell apoptosis by phosphorylating key regulatory factors including p53/TP53 and Yes-associates protein YAP1 (PubMed:21364637). In T-cells, MAPK8 and MAPK9 are required for polarized differentiation of T-helper cells into Th1 cells. Contributes to the survival of erythroid cells by phosphorylating the antagonist of cell death BAD upon EPO stimulation (PubMed:21095239). Mediates starvation-induced BCL2 phosphorylation, BCL2 dissociation from BECN1, and thus activation of autophagy (PubMed:18570871). Phosphorylates STMN2 and hence regulates microtubule dynamics, controlling neurite elongation in cortical neurons (By similarity). In the developing brain, through its cytoplasmic activity on STMN2, negatively regulates the rate of exit from multipolar stage and of radial migration from the ventricular zone (By similarity). Phosphorylates several other substrates including heat shock factor protein 4 (HSF4), the deacetylase SIRT1, ELK1, or the E3 ligase ITCH (PubMed:16581800, PubMed:17296730, PubMed:20027304). Phosphorylates the CLOCK-BMAL1 heterodimer and plays a role in the regulation of the circadian clock (PubMed:22441692). Phosphorylates the heat shock transcription factor HSF1, suppressing HSF1-induced transcriptional activity (PubMed:10747973). Phosphorylates POU5F1, which results in the inhibition of POU5F1's transcriptional activity and enhances its proteasomal degradation (By similarity). Phosphorylates JUND and this phosphorylation is inhibited in the presence of MEN1 (PubMed:22327296). In neurons, phosphorylates SYT4 which captures neuronal dense core vesicles at synapses (By similarity). Phosphorylates EIF4ENIF1/4-ET in response to oxidative stress, promoting P-body assembly (PubMed:22966201). Phosphorylates SIRT6 in response to oxidative stress, stimulating its mono-ADP-ribosyltransferase activity (PubMed:27568560). Phosphorylates NLRP3, promoting assembly of the NLRP3 inflammasome (PubMed:28943315). Phosphorylates ALKBH5 in response to reactive oxygen species (ROS), promoting ALKBH5 sumoylation and inactivation (PubMed:34048572) JNK1 isoforms display different binding patterns: beta-1 preferentially binds to c-Jun, whereas alpha-1, alpha-2, and beta-2 have a similar low level of binding to both c-Jun or ATF2. However, there is no correlation between binding and phosphorylation, which is achieved at about the same efficiency by all isoforms","subcellular_location":"Cytoplasm; Nucleus; Synapse","url":"https://www.uniprot.org/uniprotkb/P45983/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/MAPK8","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000107643","cell_line_id":"CID001207","localizations":[{"compartment":"cytoplasmic","grade":3},{"compartment":"nucleoplasm","grade":3}],"interactors":[{"gene":"WDR62","stoichiometry":0.2},{"gene":"MAP2K4","stoichiometry":0.2},{"gene":"PHKG2","stoichiometry":0.2},{"gene":"MAPK9","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID001207","total_profiled":1310},"omim":[{"mim_id":"621533","title":"NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND IMPAIRED INTELLECTUAL AND LANGUAGE DEVELOPMENT; NEDSIL","url":"https://www.omim.org/entry/621533"},{"mim_id":"621025","title":"RAB3A-INTERACTING PROTEIN-LIKE 1; RAB3IL1","url":"https://www.omim.org/entry/621025"},{"mim_id":"619589","title":"BRAF-ACTIVATED NONCODING RNA; BANCR","url":"https://www.omim.org/entry/619589"},{"mim_id":"619456","title":"CDC42 SMALL EFFECTOR 1; CDC42SE1","url":"https://www.omim.org/entry/619456"},{"mim_id":"618476","title":"BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS","url":"https://www.omim.org/entry/618476"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/MAPK8"},"hgnc":{"alias_symbol":["JNK","JNK1","SAPK1"],"prev_symbol":["PRKM8"]},"alphafold":{"accession":"P45983","domains":[{"cath_id":"3.30.200.20","chopping":"7-111","consensus_level":"high","plddt":91.3832,"start":7,"end":111},{"cath_id":"1.10.510.10","chopping":"114-332","consensus_level":"high","plddt":90.6115,"start":114,"end":332}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P45983","model_url":"https://alphafold.ebi.ac.uk/files/AF-P45983-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P45983-F1-predicted_aligned_error_v6.png","plddt_mean":82.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=MAPK8","jax_strain_url":"https://www.jax.org/strain/search?query=MAPK8"},"sequence":{"accession":"P45983","fasta_url":"https://rest.uniprot.org/uniprotkb/P45983.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P45983/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P45983"}},"corpus_meta":[{"pmid":"18931691","id":"PMC_18931691","title":"JNK signaling in apoptosis.","date":"2008","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/18931691","citation_count":1265,"is_preprint":false},{"pmid":"10064598","id":"PMC_10064598","title":"Regulation of JNK signaling by GSTp.","date":"1999","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/10064598","citation_count":922,"is_preprint":false},{"pmid":"7855889","id":"PMC_7855889","title":"MAPKs: new JNK expands the group.","date":"1994","source":"Trends in biochemical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/7855889","citation_count":908,"is_preprint":false},{"pmid":"17303404","id":"PMC_17303404","title":"The JNK signal transduction pathway.","date":"2007","source":"Current opinion in cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/17303404","citation_count":894,"is_preprint":false},{"pmid":"10230788","id":"PMC_10230788","title":"The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development.","date":"1999","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/10230788","citation_count":762,"is_preprint":false},{"pmid":"11790549","id":"PMC_11790549","title":"The JNK signal transduction pathway.","date":"2002","source":"Current opinion in genetics & development","url":"https://pubmed.ncbi.nlm.nih.gov/11790549","citation_count":578,"is_preprint":false},{"pmid":"12815381","id":"PMC_12815381","title":"Targeting JNK for therapeutic benefit: from junk to gold?","date":"2003","source":"Nature reviews. Drug discovery","url":"https://pubmed.ncbi.nlm.nih.gov/12815381","citation_count":506,"is_preprint":false},{"pmid":"10367887","id":"PMC_10367887","title":"Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1.","date":"1999","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/10367887","citation_count":502,"is_preprint":false},{"pmid":"9851932","id":"PMC_9851932","title":"Defective T cell differentiation in the absence of Jnk1.","date":"1998","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/9851932","citation_count":502,"is_preprint":false},{"pmid":"12818176","id":"PMC_12818176","title":"JNK-mediated BIM phosphorylation potentiates BAX-dependent apoptosis.","date":"2003","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/12818176","citation_count":434,"is_preprint":false},{"pmid":"12853963","id":"PMC_12853963","title":"JNK phosphorylates paxillin and regulates cell migration.","date":"2003","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/12853963","citation_count":412,"is_preprint":false},{"pmid":"17082773","id":"PMC_17082773","title":"JNK- and Fos-regulated Mmp1 expression cooperates with Ras to induce invasive tumors in Drosophila.","date":"2006","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/17082773","citation_count":335,"is_preprint":false},{"pmid":"24739785","id":"PMC_24739785","title":"Nuclear and cytosolic JNK signalling in neurons.","date":"2014","source":"Nature reviews. Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/24739785","citation_count":272,"is_preprint":false},{"pmid":"20371626","id":"PMC_20371626","title":"JNK1 and IKKbeta: molecular links between obesity and metabolic dysfunction.","date":"2010","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/20371626","citation_count":268,"is_preprint":false},{"pmid":"17538955","id":"PMC_17538955","title":"The functional contrariety of JNK.","date":"2007","source":"Molecular carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/17538955","citation_count":229,"is_preprint":false},{"pmid":"20027304","id":"PMC_20027304","title":"JNK1 phosphorylates SIRT1 and promotes its enzymatic activity.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20027304","citation_count":224,"is_preprint":false},{"pmid":"17584114","id":"PMC_17584114","title":"JNK signalling: a possible target to prevent neurodegeneration.","date":"2007","source":"Current pharmaceutical design","url":"https://pubmed.ncbi.nlm.nih.gov/17584114","citation_count":207,"is_preprint":false},{"pmid":"9003777","id":"PMC_9003777","title":"HPK1, a hematopoietic protein kinase activating the SAPK/JNK pathway.","date":"1996","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/9003777","citation_count":205,"is_preprint":false},{"pmid":"12734425","id":"PMC_12734425","title":"Role of JNK in tumor development.","date":"2003","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/12734425","citation_count":195,"is_preprint":false},{"pmid":"19053047","id":"PMC_19053047","title":"Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance.","date":"2009","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/19053047","citation_count":189,"is_preprint":false},{"pmid":"19638343","id":"PMC_19638343","title":"JNK1-dependent PUMA expression contributes to hepatocyte lipoapoptosis.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19638343","citation_count":166,"is_preprint":false},{"pmid":"11062067","id":"PMC_11062067","title":"Synergistic activation of stress-activated protein kinase 1/c-Jun N-terminal kinase (SAPK1/JNK) isoforms by mitogen-activated protein kinase kinase 4 (MKK4) and MKK7.","date":"2000","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/11062067","citation_count":164,"is_preprint":false},{"pmid":"9889102","id":"PMC_9889102","title":"Synergistic activation of SAPK1/JNK1 by two MAP kinase kinases in vitro.","date":"1998","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/9889102","citation_count":164,"is_preprint":false},{"pmid":"16061178","id":"PMC_16061178","title":"RACK1 mediates activation of JNK by protein kinase C [corrected].","date":"2005","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/16061178","citation_count":158,"is_preprint":false},{"pmid":"17439715","id":"PMC_17439715","title":"JNK pathway: diseases and therapeutic potential.","date":"2007","source":"Acta pharmacologica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/17439715","citation_count":155,"is_preprint":false},{"pmid":"16618812","id":"PMC_16618812","title":"JNK1 phosphorylation of SCG10 determines microtubule dynamics and axodendritic length.","date":"2006","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/16618812","citation_count":154,"is_preprint":false},{"pmid":"20452774","id":"PMC_20452774","title":"cJun NH2-terminal kinase 1 (JNK1): roles in metabolic regulation of insulin resistance.","date":"2010","source":"Trends in biochemical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/20452774","citation_count":144,"is_preprint":false},{"pmid":"19521338","id":"PMC_19521338","title":"JNK signalling modulates intestinal homeostasis and tumourigenesis in mice.","date":"2009","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/19521338","citation_count":140,"is_preprint":false},{"pmid":"24349637","id":"PMC_24349637","title":"The 2 Faces of JNK Signaling in Cancer.","date":"2013","source":"Genes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/24349637","citation_count":137,"is_preprint":false},{"pmid":"23051914","id":"PMC_23051914","title":"Attenuation of TNFSF10/TRAIL-induced apoptosis by an autophagic survival pathway involving TRAF2- and RIPK1/RIP1-mediated MAPK8/JNK activation.","date":"2012","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/23051914","citation_count":132,"is_preprint":false},{"pmid":"19945406","id":"PMC_19945406","title":"Prevention of steatosis by hepatic JNK1.","date":"2009","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/19945406","citation_count":131,"is_preprint":false},{"pmid":"18455869","id":"PMC_18455869","title":"Activation of JNK pathway in persistent pain.","date":"2008","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/18455869","citation_count":128,"is_preprint":false},{"pmid":"22340717","id":"PMC_22340717","title":"Role of the JNK pathway in human diseases.","date":"2012","source":"Progress in molecular biology and translational science","url":"https://pubmed.ncbi.nlm.nih.gov/22340717","citation_count":127,"is_preprint":false},{"pmid":"17525747","id":"PMC_17525747","title":"Cooperation between JNK1 and JNK2 in activation of p53 apoptotic pathway.","date":"2007","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/17525747","citation_count":116,"is_preprint":false},{"pmid":"19466550","id":"PMC_19466550","title":"Correcting developmental errors by apoptosis: lessons from Drosophila JNK signaling.","date":"2009","source":"Apoptosis : an international journal on programmed cell death","url":"https://pubmed.ncbi.nlm.nih.gov/19466550","citation_count":112,"is_preprint":false},{"pmid":"14609950","id":"PMC_14609950","title":"Glucocorticoid receptor-JNK interaction mediates inhibition of the JNK pathway by glucocorticoids.","date":"2003","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/14609950","citation_count":104,"is_preprint":false},{"pmid":"21111799","id":"PMC_21111799","title":"Regulation of Drosophila lifespan by JNK signaling.","date":"2010","source":"Experimental gerontology","url":"https://pubmed.ncbi.nlm.nih.gov/21111799","citation_count":101,"is_preprint":false},{"pmid":"21123811","id":"PMC_21123811","title":"The role of JNK proteins in metabolism.","date":"2010","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/21123811","citation_count":95,"is_preprint":false},{"pmid":"15611622","id":"PMC_15611622","title":"NF-kappaB and JNK: an intricate affair.","date":"2004","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/15611622","citation_count":93,"is_preprint":false},{"pmid":"20231429","id":"PMC_20231429","title":"Platelet JNK1 is involved in secretion and thrombus formation.","date":"2010","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/20231429","citation_count":92,"is_preprint":false},{"pmid":"28112734","id":"PMC_28112734","title":"JNK1 negatively controls antifungal innate immunity by suppressing CD23 expression.","date":"2017","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28112734","citation_count":86,"is_preprint":false},{"pmid":"29267206","id":"PMC_29267206","title":"JNK, p38, ERK, and SGK1 Inhibitors in Cancer.","date":"2017","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/29267206","citation_count":84,"is_preprint":false},{"pmid":"36396625","id":"PMC_36396625","title":"BNIP3 phosphorylation by JNK1/2 promotes mitophagy via enhancing its stability under hypoxia.","date":"2022","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/36396625","citation_count":82,"is_preprint":false},{"pmid":"11278263","id":"PMC_11278263","title":"Protein kinase G activates the JNK1 pathway via phosphorylation of MEKK1.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11278263","citation_count":72,"is_preprint":false},{"pmid":"18220583","id":"PMC_18220583","title":"Oxidative stress and the JNK pathway in diabetes.","date":"2005","source":"Current diabetes reviews","url":"https://pubmed.ncbi.nlm.nih.gov/18220583","citation_count":70,"is_preprint":false},{"pmid":"33918666","id":"PMC_33918666","title":"JNK Pathway in CNS Pathologies.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33918666","citation_count":68,"is_preprint":false},{"pmid":"32598968","id":"PMC_32598968","title":"JNK signaling in Drosophila immunity and homeostasis.","date":"2020","source":"Immunology letters","url":"https://pubmed.ncbi.nlm.nih.gov/32598968","citation_count":67,"is_preprint":false},{"pmid":"28174264","id":"PMC_28174264","title":"Hippo signaling promotes JNK-dependent cell migration.","date":"2017","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/28174264","citation_count":67,"is_preprint":false},{"pmid":"16682809","id":"PMC_16682809","title":"JNK regulation of oncogenesis.","date":"2006","source":"Molecules and cells","url":"https://pubmed.ncbi.nlm.nih.gov/16682809","citation_count":67,"is_preprint":false},{"pmid":"19251431","id":"PMC_19251431","title":"Insulin and JNK: optimizing metabolic homeostasis and lifespan.","date":"2009","source":"Trends in endocrinology and metabolism: TEM","url":"https://pubmed.ncbi.nlm.nih.gov/19251431","citation_count":66,"is_preprint":false},{"pmid":"15377263","id":"PMC_15377263","title":"JNK: a key modulator of intracellular signaling.","date":"2004","source":"Biochemistry. Biokhimiia","url":"https://pubmed.ncbi.nlm.nih.gov/15377263","citation_count":65,"is_preprint":false},{"pmid":"31817617","id":"PMC_31817617","title":"Phosphorylation Dynamics of JNK Signaling: Effects of Dual-Specificity Phosphatases (DUSPs) on the JNK Pathway.","date":"2019","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31817617","citation_count":63,"is_preprint":false},{"pmid":"34502556","id":"PMC_34502556","title":"The Roles of c-Jun N-Terminal Kinase (JNK) in Infectious Diseases.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34502556","citation_count":61,"is_preprint":false},{"pmid":"19903520","id":"PMC_19903520","title":"JNK inhibition and inflammation after cerebral ischemia.","date":"2009","source":"Brain, behavior, and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/19903520","citation_count":60,"is_preprint":false},{"pmid":"30236054","id":"PMC_30236054","title":"The sucrose non-fermenting-1-related protein kinases SAPK1 and SAPK2 function collaboratively as positive regulators of salt stress tolerance in rice.","date":"2018","source":"BMC plant biology","url":"https://pubmed.ncbi.nlm.nih.gov/30236054","citation_count":59,"is_preprint":false},{"pmid":"10064599","id":"PMC_10064599","title":"c-Jun functions as a calcium-regulated transcriptional activator in the absence of JNK/SAPK1 activation.","date":"1999","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/10064599","citation_count":59,"is_preprint":false},{"pmid":"28812968","id":"PMC_28812968","title":"JNK pathway in osteoarthritis: pathological and therapeutic aspects.","date":"2017","source":"Journal of receptor and signal transduction research","url":"https://pubmed.ncbi.nlm.nih.gov/28812968","citation_count":58,"is_preprint":false},{"pmid":"11689607","id":"PMC_11689607","title":"Reovirus infection activates JNK and the JNK-dependent transcription factor c-Jun.","date":"2001","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/11689607","citation_count":56,"is_preprint":false},{"pmid":"12769633","id":"PMC_12769633","title":"Targeting the JNK pathway for therapeutic benefit in CNS disease.","date":"2002","source":"Current drug targets. CNS and neurological disorders","url":"https://pubmed.ncbi.nlm.nih.gov/12769633","citation_count":53,"is_preprint":false},{"pmid":"33114371","id":"PMC_33114371","title":"Alarmins and c-Jun N-Terminal Kinase (JNK) Signaling in Neuroinflammation.","date":"2020","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/33114371","citation_count":51,"is_preprint":false},{"pmid":"10648896","id":"PMC_10648896","title":"Selective expression of JNK isoforms and stress-specific JNK activity in different neural cell lines.","date":"2000","source":"Brain research. Molecular brain research","url":"https://pubmed.ncbi.nlm.nih.gov/10648896","citation_count":49,"is_preprint":false},{"pmid":"25925693","id":"PMC_25925693","title":"Fumonisin B1 induces autophagic cell death via activation of ERN1-MAPK8/9/10 pathway in monkey kidney MARC-145 cells.","date":"2015","source":"Archives of toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/25925693","citation_count":48,"is_preprint":false},{"pmid":"30119215","id":"PMC_30119215","title":"MAPK8 mediates resistance to temozolomide and apoptosis of glioblastoma cells through MAPK signaling pathway.","date":"2018","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/30119215","citation_count":47,"is_preprint":false},{"pmid":"20581839","id":"PMC_20581839","title":"Interplay between Cdh1 and JNK activity during the cell cycle.","date":"2010","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/20581839","citation_count":47,"is_preprint":false},{"pmid":"9305750","id":"PMC_9305750","title":"SKK4, a novel activator of stress-activated protein kinase-1 (SAPK1/JNK).","date":"1997","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/9305750","citation_count":45,"is_preprint":false},{"pmid":"24349639","id":"PMC_24349639","title":"Network Motifs in JNK Signaling.","date":"2013","source":"Genes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/24349639","citation_count":45,"is_preprint":false},{"pmid":"22394200","id":"PMC_22394200","title":"JNK- and Akt-mediated Puma expression in the apoptosis of cisplatin-resistant ovarian cancer cells.","date":"2012","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/22394200","citation_count":44,"is_preprint":false},{"pmid":"31295022","id":"PMC_31295022","title":"JNK1 regulates RANKL-induced osteoclastogenesis via activation of a novel Bcl-2-Beclin1-autophagy pathway.","date":"2019","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/31295022","citation_count":43,"is_preprint":false},{"pmid":"33710509","id":"PMC_33710509","title":"JNK signaling as a target for anticancer therapy.","date":"2021","source":"Pharmacological reports : PR","url":"https://pubmed.ncbi.nlm.nih.gov/33710509","citation_count":41,"is_preprint":false},{"pmid":"27002406","id":"PMC_27002406","title":"Glabridin induces apoptosis and autophagy through JNK1/2 pathway in human hepatoma cells.","date":"2016","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/27002406","citation_count":41,"is_preprint":false},{"pmid":"21305529","id":"PMC_21305529","title":"JNK-1 deficiency limits macrophage-mediated antigen-induced arthritis.","date":"2011","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/21305529","citation_count":41,"is_preprint":false},{"pmid":"30151339","id":"PMC_30151339","title":"JNK Regulation of Depression and Anxiety.","date":"2018","source":"Brain plasticity (Amsterdam, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/30151339","citation_count":40,"is_preprint":false},{"pmid":"23865415","id":"PMC_23865415","title":"Emerging role of JNK in insulin resistance.","date":"2013","source":"Current diabetes reviews","url":"https://pubmed.ncbi.nlm.nih.gov/23865415","citation_count":40,"is_preprint":false},{"pmid":"28229641","id":"PMC_28229641","title":"Food additives: Sodium benzoate, potassium sorbate, azorubine, and tartrazine modify the expression of NFκB, GADD45α, and MAPK8 genes.","date":"2016","source":"Physiology international","url":"https://pubmed.ncbi.nlm.nih.gov/28229641","citation_count":39,"is_preprint":false},{"pmid":"27347203","id":"PMC_27347203","title":"JNK1/2 expression and modulation of STAT3 signaling in oral cancer.","date":"2016","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/27347203","citation_count":39,"is_preprint":false},{"pmid":"31270248","id":"PMC_31270248","title":"JNK and cardiometabolic dysfunction.","date":"2019","source":"Bioscience reports","url":"https://pubmed.ncbi.nlm.nih.gov/31270248","citation_count":38,"is_preprint":false},{"pmid":"18249159","id":"PMC_18249159","title":"ATF3 and Fra1 have opposite functions in JNK- and ERK-dependent DNA damage responses.","date":"2008","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/18249159","citation_count":38,"is_preprint":false},{"pmid":"19478459","id":"PMC_19478459","title":"JNK1 determines the oncogenic or tumor-suppressive activity of the integrin-linked kinase in human rhabdomyosarcoma.","date":"2009","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/19478459","citation_count":38,"is_preprint":false},{"pmid":"25269780","id":"PMC_25269780","title":"Crosstalk of JNK1-STAT3 is critical for RAW264.7 cell survival.","date":"2014","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/25269780","citation_count":37,"is_preprint":false},{"pmid":"32039671","id":"PMC_32039671","title":"Recent Advances in c-Jun N-Terminal Kinase (JNK) Inhibitors.","date":"2021","source":"Current medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32039671","citation_count":36,"is_preprint":false},{"pmid":"32199908","id":"PMC_32199908","title":"Inactivation of Hippo and cJun-N-terminal Kinase (JNK) signaling mitigate FUS mediated neurodegeneration in vivo.","date":"2020","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/32199908","citation_count":36,"is_preprint":false},{"pmid":"15277532","id":"PMC_15277532","title":"Sef interacts with TAK1 and mediates JNK activation and apoptosis.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15277532","citation_count":36,"is_preprint":false},{"pmid":"24475223","id":"PMC_24475223","title":"JNK1 protects against glucolipotoxicity-mediated beta-cell apoptosis.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24475223","citation_count":36,"is_preprint":false},{"pmid":"19591900","id":"PMC_19591900","title":"JNK1, a potential therapeutic target for hepatocellular carcinoma.","date":"2009","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/19591900","citation_count":35,"is_preprint":false},{"pmid":"26974344","id":"PMC_26974344","title":"Localized JNK signaling regulates organ size during development.","date":"2016","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/26974344","citation_count":35,"is_preprint":false},{"pmid":"36693850","id":"PMC_36693850","title":"USP14 promotes colorectal cancer progression by targeting JNK for stabilization.","date":"2023","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/36693850","citation_count":34,"is_preprint":false},{"pmid":"33200240","id":"PMC_33200240","title":"Brain JNK and metabolic disease.","date":"2020","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/33200240","citation_count":33,"is_preprint":false},{"pmid":"27216154","id":"PMC_27216154","title":"JNK1 Inhibition Attenuates Hypoxia-Induced Autophagy and Sensitizes to Chemotherapy.","date":"2016","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/27216154","citation_count":33,"is_preprint":false},{"pmid":"29856313","id":"PMC_29856313","title":"The cJUN NH2-terminal kinase (JNK) signaling pathway promotes genome stability and prevents tumor initiation.","date":"2018","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/29856313","citation_count":31,"is_preprint":false},{"pmid":"24868495","id":"PMC_24868495","title":"JNK is a novel regulator of intercellular adhesion.","date":"2013","source":"Tissue barriers","url":"https://pubmed.ncbi.nlm.nih.gov/24868495","citation_count":31,"is_preprint":false},{"pmid":"29372681","id":"PMC_29372681","title":"CtBP impedes JNK- and Upd/STAT-driven cell fate misspecifications in regenerating Drosophila imaginal discs.","date":"2018","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/29372681","citation_count":30,"is_preprint":false},{"pmid":"14737674","id":"PMC_14737674","title":"Synthetic anisomycin analogues activating the JNK/SAPK1 and p38/SAPK2 pathways.","date":"2003","source":"Organic & biomolecular chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14737674","citation_count":29,"is_preprint":false},{"pmid":"22302822","id":"PMC_22302822","title":"JNK1 inhibits GluR1 expression and GluR1-mediated calcium influx through phosphorylation and stabilization of Hes-1.","date":"2012","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/22302822","citation_count":29,"is_preprint":false},{"pmid":"16679020","id":"PMC_16679020","title":"Players in the PARP-1 cell-death pathway: JNK1 joins the cast.","date":"2006","source":"Trends in biochemical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/16679020","citation_count":29,"is_preprint":false},{"pmid":"31539158","id":"PMC_31539158","title":"TLR4 promotes liver inflammation by activating the JNK pathway.","date":"2019","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31539158","citation_count":29,"is_preprint":false},{"pmid":"29940159","id":"PMC_29940159","title":"RhoA regulates Schwann cell differentiation through JNK pathway.","date":"2018","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/29940159","citation_count":28,"is_preprint":false},{"pmid":"32213714","id":"PMC_32213714","title":"Irreversible JNK1-JUN inhibition by JNK-IN-8 sensitizes pancreatic cancer to 5-FU/FOLFOX chemotherapy.","date":"2020","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/32213714","citation_count":28,"is_preprint":false},{"pmid":"36068777","id":"PMC_36068777","title":"Diacerein protects liver against APAP-induced injury via targeting JNK and inhibiting JNK-mediated oxidative stress and apoptosis.","date":"2022","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/36068777","citation_count":27,"is_preprint":false},{"pmid":"20959642","id":"PMC_20959642","title":"Preantral follicle growth is regulated by c-Jun-N-terminal kinase (JNK) pathway.","date":"2010","source":"Reproductive sciences (Thousand Oaks, Calif.)","url":"https://pubmed.ncbi.nlm.nih.gov/20959642","citation_count":27,"is_preprint":false},{"pmid":"18222916","id":"PMC_18222916","title":"Phosphorylation of mitogen-activated protein kinase 8 (MAPK8) is associated with germ cell apoptosis and redistribution of the Bcl2-modifying factor (BMF).","date":"2008","source":"Journal of andrology","url":"https://pubmed.ncbi.nlm.nih.gov/18222916","citation_count":25,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":41731,"output_tokens":7607,"usd":0.119649,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":16732,"output_tokens":5644,"usd":0.11238,"stage2_stop_reason":"end_turn"},"total_usd":0.232029,"stage1_batch_id":"msgbatch_01BbTCMyrRPyhtEq6b1MdwCN","stage2_batch_id":"msgbatch_011dEed5bbxYvTAaQWKJevxu","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"GSTp (glutathione S-transferase Pi) was purified and identified as a JNK-associated inhibitor protein. Monomeric GSTp inhibits JNK activity in a dose-dependent manner; UV irradiation or H2O2 treatment causes GSTp oligomerization and dissociation of the GSTp-JNK complex, relieving inhibition. GSTp inhibition of JNK is independent of the MEKK1-MKK4 module.\",\n      \"method\": \"Protein purification, co-immunoprecipitation, in vitro kinase assay with purified GSTp, immunodepletion, forced expression/cDNA complementation in GSTp-null MEFs\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple orthogonal methods (purification, Co-IP, in vitro activity assay, genetic knockout MEFs, siRNA/inhibitor studies) in a single rigorous study with strong mechanistic follow-up\",\n      \"pmids\": [\"10064598\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"MKK4 and MKK7 synergistically activate SAPK1/JNK1 in vitro: MKK4 preferentially phosphorylates the tyrosine residue (Tyr-185) and MKK7 preferentially phosphorylates the threonine residue (Thr-183) within the Thr-Pro-Tyr activation motif, such that both kinases together produce synergistic activation.\",\n      \"method\": \"In vitro kinase assay, site-specific phosphorylation analysis\",\n      \"journal\": \"Current biology : CB\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with site-specific phosphorylation mapping, replicated in a subsequent independent study (PMID 11062067)\",\n      \"pmids\": [\"9889102\", \"11062067\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"MKK4 shows striking preference for phosphorylation of Tyr-185, and MKK7 shows striking preference for Thr-183 in JNK1α1, JNK2α2, and JNK3α1 isoforms, producing synergistic activation when combined. MKK7 also phosphorylates JNK2α2 at Thr-404 and Ser-407 in vitro and in cells.\",\n      \"method\": \"In vitro kinase assay with three SAPK1/JNK isoforms, phospho-specific immunoblotting in KB cells and HEK-293 cells\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with site-specific mutagenesis/mapping across multiple isoforms, corroborated by cell-based phosphorylation studies\",\n      \"pmids\": [\"11062067\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"JNK1 phosphorylates paxillin at Ser178 both in vitro and in intact cells. Expression of the Ser178→Ala paxillin mutant inhibited rapid cell migration in fish keratocytes and NBT-II cells, blocking the labile adhesions required for rapid movement.\",\n      \"method\": \"In vitro kinase assay, site-directed mutagenesis, single-cell migration and wound-healing assays\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro phosphorylation assay with mutagenesis validation, functional phenotype confirmed in multiple cell types across two migration assay formats\",\n      \"pmids\": [\"12853963\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"JNK phosphorylates BIM(EL) at Ser65, potentiating its proapoptotic activity. Mitochondrially localized JNK specifically phosphorylates BIM(EL), whereas upstream activators (MLKs, MKKs) do not. This phosphorylation both promotes BIM(EL) expression transcriptionally and increases its proapoptotic activity posttranslationally.\",\n      \"method\": \"In vitro kinase assay, site-directed mutagenesis (Ser65), subcellular fractionation, loss-of-function JNK pathway inhibition with functional apoptosis readouts\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — in vitro phosphorylation with mutagenesis, mitochondrial localization established by fractionation, complementary gain/loss-of-function experiments\",\n      \"pmids\": [\"12818176\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"RACK1 serves as an adaptor for PKC-mediated JNK activation. PKC phosphorylates JNK on Ser129 in a RACK1-dependent manner; Ser129 phosphorylation augments subsequent JNK phosphorylation by MKK4/MKK7 and is required for JNK activation by TPA, TNFα, UV irradiation, and PKC, but not by anisomycin or MEKK1.\",\n      \"method\": \"Co-immunoprecipitation, site-directed mutagenesis (Ser129), siRNA knockdown of RACK1, in vitro kinase assay\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — Co-IP, site-specific mutagenesis, and siRNA knockdown with multiple stimuli and functional readouts in single study\",\n      \"pmids\": [\"16061178\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"JNK1 phosphorylates SCG10 (a stathmin-family microtubule-destabilizing protein) in vivo at Ser62 and Ser73, regulating its microtubule-depolymerizing activity. SCG10-S73 phosphorylation is significantly decreased in JNK1-/- cortex. JNK1 phosphorylation of SCG10 determines axodendritic length in cerebrocortical cultures.\",\n      \"method\": \"Affinity purification of JNK-interacting proteins from brain, in vivo phosphorylation with phospho-site mapping, JNK1-/- mouse cortex analysis, FRAP (fluorescent tubulin recovery), neurite length assays\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — in vivo phosphorylation validated in knockout mice, multiple orthogonal methods including FRAP and neurite assays\",\n      \"pmids\": [\"16618812\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"JNK1 physically interacts with SIRT1 under oxidative stress conditions (co-immunoprecipitation of endogenous proteins). JNK1 phosphorylates SIRT1 at Ser27, Ser47, and Thr530, increasing SIRT1 nuclear localization and enzymatic activity with substrate specificity: phosphorylated SIRT1 deacetylates histone H3 but not p53.\",\n      \"method\": \"Co-immunoprecipitation of endogenous proteins, in vitro kinase assay, site-directed mutagenesis, nuclear fractionation, SIRT1 enzymatic activity assay, RNAi\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — endogenous Co-IP, in vitro phosphorylation with site mapping, functional enzymatic activity measurements, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"20027304\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Nuclear-localized JNK is degraded by the APC/C(Cdh1) ubiquitin ligase during exit from mitosis and G1 phase. Conversely, JNK phosphorylates Cdh1 during G2 and early mitosis, changing Cdh1 subcellular localization and attenuating its ability to activate the APC/C during G2/M.\",\n      \"method\": \"Co-immunoprecipitation, subcellular fractionation, in vitro kinase assay, expression of non-degradable JNK mutant, cell cycle synchronization\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — reciprocal regulation demonstrated by multiple methods including in vitro phosphorylation, non-degradable mutant overexpression, and APC/C activity assays\",\n      \"pmids\": [\"20581839\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"HPK1 (hematopoietic progenitor kinase 1) specifically activates the SAPK/JNK pathway after transfection, acting via the SH3-containing mixed lineage kinase MLK-3 and the known SAPK activator SEK1 (MKK4). HPK1 does not stimulate p38/RK or ERK pathways.\",\n      \"method\": \"Transfection into COS1 cells, pathway-specific kinase activity assays, epistasis with dominant-negative pathway components\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis in cell-based system with pathway specificity controls, single lab\",\n      \"pmids\": [\"9003777\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Protein kinase G (PKG) activates JNK1 through a PKG-MEKK1-SEK1-JNK1 pathway by directly phosphorylating MEKK1. A dominant-negative MEKK1 inhibited PKG-induced JNK1 activation and c-Jun transactivation. In vitro assays showed purified PKG directly phosphorylated the N-terminal domain of MEKK1.\",\n      \"method\": \"In vitro kinase assay with purified PKG and MEKK1, constitutively active PKG mutant expression, dominant-negative MEKK1 epistasis, AP-1 reporter assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — in vitro kinase reconstitution with epistasis, single lab with multiple complementary methods\",\n      \"pmids\": [\"11278263\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Glucocorticoid receptor (GR) inhibits JNK activation by physically associating with JNK upon glucocorticoid treatment, promoting disassembly of JNK from MKK7. A hormone-regulated JNK docking site was characterized in the GR ligand-binding domain. GC-induced GR-JNK association correlates with increased loading of inactive JNK on AP-1-bound response elements of the c-jun gene.\",\n      \"method\": \"Co-immunoprecipitation, domain mapping mutagenesis, chromatin immunoprecipitation (ChIP), inactive JNK nuclear transfer assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — Co-IP with domain mutagenesis, ChIP validation, and mechanistic dissection of GR-JNK interaction with multiple functional readouts\",\n      \"pmids\": [\"14609950\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"JNK1 signaling is required for T cell receptor-initiated TH cell proliferation, apoptosis, and differentiation. Jnk1-/- T cells hyperproliferate, show decreased activation-induced cell death, and preferentially differentiate to TH2 cells. Enhanced TH2 cytokine production is associated with increased nuclear accumulation of NFATc.\",\n      \"method\": \"Jnk1 knockout mouse analysis, T cell activation assays, cytokine profiling, NFATc nuclear localization assay\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic loss-of-function with defined cellular phenotypes across multiple readouts (proliferation, apoptosis, differentiation, transcription factor localization)\",\n      \"pmids\": [\"9851932\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Jnk1 and Jnk2 are jointly required for region-specific apoptosis during early brain development. Jnk1/Jnk2 double-knockout compound mutants are embryonic lethal with severe dysregulation of apoptosis: reduced cell death in lateral hindbrain and increased apoptosis/caspase activation in forebrain.\",\n      \"method\": \"Jnk1-/-, Jnk2-/-, Jnk3-/- single and compound knockout mice, histological analysis, caspase activation assays\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic loss-of-function in vivo with defined region-specific apoptotic phenotypes and caspase activation measurements\",\n      \"pmids\": [\"10230788\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"JNK1-dependent PUMA expression contributes to hepatocyte lipoapoptosis. Palmitate induction of PUMA is JNK1-dependent in primary murine hepatocytes; phosphorylated c-Jun in an AP-1 complex directly binds the PUMA promoter as shown by EMSA and ChIP. PUMA knockdown attenuated Bax activation, caspase 3/7 activity, and cell death.\",\n      \"method\": \"JNK1 knockout primary hepatocytes, dominant-negative c-Jun, EMSA, chromatin immunoprecipitation (ChIP), shRNA knockdown, caspase activity assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — genetic knockout, ChIP, EMSA, and shRNA with multiple functional readouts in a single mechanistic study\",\n      \"pmids\": [\"19638343\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Hepatic JNK1 prevents steatosis: mice with specific ablation of Jnk1 in hepatocytes develop glucose intolerance, insulin resistance, and hepatic steatosis, demonstrating that JNK1 serves opposing actions in liver versus adipose tissue.\",\n      \"method\": \"Hepatocyte-specific Jnk1 conditional knockout mice, glucose tolerance tests, insulin sensitivity assays, histological analysis of liver\",\n      \"journal\": \"Cell metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — tissue-specific conditional knockout with defined metabolic phenotypes, multiple physiological readouts\",\n      \"pmids\": [\"19945406\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"JNK2-deficient mice on high-fat diet show increased liver injury through a Bim-dependent activation of the mitochondrial death pathway. JNK2 ablation increases hepatic expression of proapoptotic Bcl-2 family members Bim and Bax, revealing that JNK1 and JNK2 have distinct isoform-specific effects on steatohepatitis.\",\n      \"method\": \"Jnk1-/- and Jnk2-/- knockout mice, antisense oligonucleotide knockdown, high-fat diet model, Western blot for apoptotic proteins, histological analysis\",\n      \"journal\": \"Hepatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — isoform-specific genetic knockouts with molecular pathway characterization across multiple readouts\",\n      \"pmids\": [\"19053047\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"JNK1/2 phosphorylates BNIP3 at Ser60/Thr66 under hypoxia, which hampers proteasomal degradation of BNIP3 and promotes mitophagy by facilitating direct binding of BNIP3 to LC3. PP1/2A dephosphorylates BNIP3 and triggers its proteasomal degradation, suppressing mitophagy.\",\n      \"method\": \"In vitro kinase assay, site-directed mutagenesis, co-immunoprecipitation (BNIP3-LC3), proteasome inhibitor assays, mitophagy readouts under hypoxia\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — in vitro phosphorylation with site mutagenesis, Co-IP for BNIP3-LC3 interaction, and functional mitophagy assays, single lab\",\n      \"pmids\": [\"36396625\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"FDH-induced p53 phosphorylation at Ser6 is carried out by JNK1 and JNK2 cooperatively: JNK1 phosphorylates JNK2 first, and then JNK2 (but not JNK1) directly phosphorylates p53 at Ser6. Pull-down assay showed JNK2 but not JNK1 physically associates with p53.\",\n      \"method\": \"siRNA knockdown of JNK1 and JNK2, pharmacological inhibitor SP600125, pull-down assay, phospho-specific Western blot\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — pull-down and siRNA with phospho-site readout, two isoforms distinguished, single lab\",\n      \"pmids\": [\"17525747\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"JNK1 is required for platelet secretion and thrombus formation in vivo. JNK1-/- platelets show impaired secretion at low agonist doses, leading to altered integrin αIIbβ3 activation and reduced platelet aggregation via a mechanism involving protein kinase C. In vivo, JNK1-/- mice show prolonged bleeding times and reduced thrombus formation.\",\n      \"method\": \"JNK1-/- knockout mice, tail-bleeding assay, whole-blood perfusion on collagen matrix, in vivo photochemical thrombosis model, in vitro platelet aggregation and secretion assays\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic loss-of-function with multiple in vitro and in vivo functional assays, PKC pathway involvement identified\",\n      \"pmids\": [\"20231429\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"JNK1 suppresses antifungal immunity by inhibiting CD23 expression through NFATc1-mediated regulation of the CD23 gene promoter. JNK1 deficiency leads to higher CD23 induction, and CD23-dependent nitric oxide production mediates the enhanced antifungal response.\",\n      \"method\": \"JNK1-/- mice, bone marrow chimeras, CD23 promoter reporter assays, NFATc1 knockdown, nitric oxide measurement, pharmacological JNK inhibition\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout with bone marrow chimeras, promoter reporter assays, and mechanistic rescue experiments\",\n      \"pmids\": [\"28112734\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"USP14 is a deubiquitinase that physically interacts with JNK and stabilizes it by removing ubiquitin modifications, thereby sustaining MAPK/JNK signaling. USP14 ablation reduces JNK protein levels and downstream pathway activation.\",\n      \"method\": \"Co-immunoprecipitation, RNA-seq, luciferase reporter assay, USP14 knockdown/knockout in vitro and in vivo, Western blot for ubiquitination\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — Co-IP and loss-of-function with pathway readout, single lab, ubiquitination mechanism inferred but deubiquitination assay details limited in abstract\",\n      \"pmids\": [\"36693850\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"TRAF2- and RIPK1-mediated MAPK8/JNK activation is required for TNFSF10/TRAIL-induced cytoprotective autophagy. MAPK8 activation mediates BCL2L1/Bcl-xL degradation and dissolution of the BCL2L1-BECN1 complex. Knockdown of TRAF2 or RIPK1 suppresses TNFSF10-induced MAPK8 activation and autophagy.\",\n      \"method\": \"siRNA knockdown of TRAF2, RIPK1, BECN1, ATG7; pharmacological inhibitors; apoptosis and autophagy assays in multiple cancer cell lines\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — multiple siRNA targets with functional autophagy/apoptosis readouts, pathway ordering established, single lab\",\n      \"pmids\": [\"23051914\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"JNK1 regulates RANKL-induced osteoclastogenesis via a Bcl-2-Beclin1-autophagy pathway: RANKL induces JNK1-dependent phosphorylation of Bcl-2, which dissociates Beclin1 from the Bcl-2-Beclin1 complex to activate autophagy. JNK1 inhibition blocks this dissociation and increases apoptosis; Beclin1 overexpression rescues autophagy deficiency caused by JNK inhibition.\",\n      \"method\": \"Pharmacological JNK inhibitor (SP600125), RNA interference, Beclin1 overexpression rescue, Western blot for Bcl-2 phosphorylation, co-immunoprecipitation of Bcl-2-Beclin1 complex, autophagy and apoptosis assays\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — Co-IP, phosphorylation analysis, and rescue experiments, single lab with multiple complementary methods\",\n      \"pmids\": [\"31295022\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"JNK1 inhibits GluR1 expression by phosphorylating Hes-1 at Ser263, stabilizing Hes-1 protein. Stabilized Hes-1 suppresses GluR1 promoter activity via N-box binding and by preventing Mash1/E47 from binding the E-box, ultimately inhibiting AMPA-evoked calcium influx in cortical neurons.\",\n      \"method\": \"In vitro kinase assay, site-directed mutagenesis (Ser263), promoter-reporter assay, chromatin immunoprecipitation, calcium imaging in cortical neurons\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — in vitro phosphorylation with site mutagenesis, ChIP, promoter reporter, and functional calcium influx assay, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"22302822\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"JNK1 determines whether integrin-linked kinase (ILK) functions as an oncogene or tumor suppressor in rhabdomyosarcoma. In ARMS cells, ILK depletion reduces JNK1/c-Jun signaling and suppresses growth; in ERMS cells, ILK depletion activates JNK1/c-Jun, promoting growth. Restoration of JNK1 in ARMS reestablishes a tumor-suppressive ILK function.\",\n      \"method\": \"RNAi-mediated ILK depletion, JNK1 restoration experiments, in vitro and in vivo growth assays, PAX3-FKHR expression in ERMS cells\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic manipulation with in vitro and in vivo functional readouts, JNK1 identified as non-canonical ILK effector, single lab\",\n      \"pmids\": [\"19478459\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"JNK pathway deficiency causes genomic instability and breast cancer development in mice. Loss of JNK signaling in breast epithelium leads to widespread early neoplasia and rapid tumor formation, identifying JNK as a tumor suppressor that prevents tumor initiation rather than controlling established tumor growth.\",\n      \"method\": \"Mammary epithelium-specific JNK knockout mice, breast cancer mouse model, genomic instability assays, tumor incidence and histological analysis\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — tissue-specific genetic knockout with defined mechanistic distinction between tumor initiation and growth suppression functions\",\n      \"pmids\": [\"29856313\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Sef physically interacts with TAK1 and activates JNK through a TAK1-MKK4-JNK pathway. Dominant-negative forms of MKK4 and TAK1 blocked Sef-mediated JNK activation and attendant apoptosis.\",\n      \"method\": \"Co-immunoprecipitation, dominant-negative epistasis constructs (MKK4-DN, TAK1-DN), apoptosis assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — Co-IP and genetic epistasis with functional apoptosis readout, single lab\",\n      \"pmids\": [\"15277532\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Active (phosphorylated) MAPK8 colocalizes with BMF in testicular germ cells upon detachment from Sertoli cells; p-MAPK8 levels increase in round spermatids and spermatocytes undergoing apoptosis after Sertoli cell removal, suggesting MAPK8 activation and BMF redistribution mediate anoikis-like apoptosis of germ cells.\",\n      \"method\": \"Immunohistochemistry, Western blot for p-MAPK8/total MAPK8, immunocytochemistry of isolated germ cells in culture\",\n      \"journal\": \"Journal of andrology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — correlative co-localization and Western blot data, no direct causal experimental manipulation of MAPK8\",\n      \"pmids\": [\"18222916\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"MAPK8/JNK1 is a stress-activated serine/threonine kinase that is dually phosphorylated on Thr183 (by MKK7) and Tyr185 (by MKK4) for full activation; it phosphorylates a broad array of substrates including transcription factors (c-Jun at Ser63/Ser73), cytoskeletal regulators (paxillin at Ser178, SCG10 at Ser62/Ser73), apoptotic mediators (BIM(EL) at Ser65, BNIP3 at Ser60/Thr66), and other signaling molecules (SIRT1 at Ser27/Ser47/Thr530, Hes-1 at Ser263, Cdh1, Bcl-2); its activity is regulated by scaffold/inhibitor proteins (GSTp, RACK1), by upstream kinases including PKC via RACK1-Ser129 phosphorylation, and by the deubiquitinase USP14 which stabilizes JNK protein; cell-type-specific and isoform-specific functions include roles in T cell differentiation, platelet secretion, hepatic lipid metabolism, antifungal immunity, neuronal cytoarchitecture, cell migration, osteoclastogenesis, and tumor suppression via genome stability maintenance.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"MAPK8/JNK1 is a stress-activated serine/threonine kinase that integrates diverse upstream signals into the phosphorylation of substrates governing apoptosis, transcription, cytoskeletal dynamics, cell-cycle progression, and tissue-specific physiology [#1, #4]. Full activation requires dual phosphorylation of its Thr-Pro-Tyr activation motif, with MKK4 preferentially modifying Tyr-185 and MKK7 preferentially modifying Thr-183, so that the two upstream kinases act synergistically across JNK isoforms [#1, #2]. The kinase is fed by multiple upstream modules — HPK1 acting through MLK-3 and MKK4 [#9], PKG via direct MEKK1 phosphorylation [#10], Sef through a TAK1–MKK4 route [#27], and PKC acting through the RACK1 adaptor to phosphorylate JNK on Ser129, which primes subsequent MKK4/MKK7 activation [#5]. JNK activity is restrained by the inhibitor GSTp, which dissociates upon oxidative stress to relieve inhibition [#0], by glucocorticoid receptor binding that displaces JNK from MKK7 [#11], and is sustained at the protein level by the deubiquitinase USP14 [#21]. Among its effectors, JNK phosphorylates the transcription factor axis and apoptotic machinery, including BIM(EL) at Ser65 to potentiate proapoptotic activity [#4], BNIP3 at Ser60/Thr66 to license LC3-dependent mitophagy [#17], Bcl-2 to release Beclin1 and drive autophagy [#23], SIRT1 at Ser27/Ser47/Thr530 to enhance its nuclear deacetylase activity [#7], Hes-1 at Ser263 to repress GluR1 transcription in neurons [#24], the cytoskeletal regulators paxillin at Ser178 for rapid cell migration [#3] and SCG10 at Ser62/Ser73 to control axodendritic length [#6], and the cell-cycle regulator Cdh1, establishing reciprocal control with the APC/C that also degrades nuclear JNK [#8]. At the organismal level, JNK1 directs TH cell proliferation, apoptosis, and TH2 differentiation [#12], guides region-specific apoptosis in brain development [#13], protects against hepatic steatosis [#15], drives hepatocyte lipoapoptosis through PUMA induction [#14], supports platelet secretion and thrombus formation [#19], and restrains antifungal immunity via NFATc1-dependent CD23 suppression [#20]. Loss of JNK signaling in breast epithelium produces genomic instability and tumor initiation, defining JNK as a tumor suppressor [#26].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Identifying HPK1 as a selective upstream activator established that JNK is engaged through a defined MLK-3/MKK4 kinase cascade distinct from the ERK and p38 pathways.\",\n      \"evidence\": \"Transfection in COS1 cells with pathway-specific kinase assays and dominant-negative epistasis\",\n      \"pmids\": [\"9003777\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological stimuli engaging HPK1 to JNK not defined\", \"Single cell-based overexpression system\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Mapping the dual-specificity input resolved how JNK reaches full activity: MKK4 and MKK7 phosphorylate distinct residues of the activation loop and act synergistically.\",\n      \"evidence\": \"In vitro kinase assays with site-specific phosphorylation mapping, extended across JNK isoforms\",\n      \"pmids\": [\"9889102\", \"11062067\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo stoichiometry of dual phosphorylation not addressed\", \"Functional consequence of MKK7-mediated Thr-404/Ser-407 phosphorylation unclear\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Jnk1 knockout T cells defined a physiological role in adaptive immunity, showing JNK1 restrains proliferation and biases TH differentiation toward TH2.\",\n      \"evidence\": \"Jnk1-/- mouse T cell activation, cytokine profiling, and NFATc localization assays\",\n      \"pmids\": [\"9851932\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct JNK1 substrates controlling NFATc accumulation not identified\", \"Isoform redundancy with JNK2 not resolved\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Discovery of GSTp as a dissociable inhibitor established a redox-gated brake on JNK independent of the MEKK1-MKK4 module.\",\n      \"evidence\": \"Protein purification, Co-IP, in vitro kinase assays, and GSTp-null MEF complementation\",\n      \"pmids\": [\"10064598\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of GSTp oligomerization-driven release not defined\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Compound knockouts showed JNK1 and JNK2 jointly govern region-specific apoptosis essential for brain morphogenesis.\",\n      \"evidence\": \"Single and compound Jnk knockout mice with histology and caspase activation assays\",\n      \"pmids\": [\"10230788\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Effector substrates mediating region-specific death not identified\", \"Mechanism of opposing forebrain vs hindbrain effects unknown\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Substrate-level studies connected JNK to cell migration and apoptosis: phosphorylation of paxillin Ser178 enables labile adhesions, and BIM(EL) Ser65 phosphorylation potentiates the mitochondrial death pathway.\",\n      \"evidence\": \"In vitro kinase assays, site mutagenesis, migration assays, and subcellular fractionation\",\n      \"pmids\": [\"12853963\", \"12818176\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Spatial control of mitochondrial vs cytoskeletal JNK pools not fully resolved\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Glucocorticoid receptor binding was shown to inhibit JNK by displacing it from MKK7, defining a hormone-regulated docking mechanism that loads inactive JNK onto AP-1 elements.\",\n      \"evidence\": \"Co-IP, domain mapping, ChIP, and inactive-JNK nuclear transfer assays\",\n      \"pmids\": [\"14609950\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Generality of inactive-JNK promoter loading across genes not established\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Identification of RACK1-dependent PKC phosphorylation of JNK Ser129 revealed a priming step required for activation by specific stimuli.\",\n      \"evidence\": \"Co-IP, Ser129 mutagenesis, RACK1 siRNA, and in vitro kinase assays across multiple stimuli\",\n      \"pmids\": [\"16061178\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural mechanism by which Ser129 priming augments MKK activation unknown\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"In vivo identification of SCG10 as a JNK1 substrate linked the kinase to neuronal microtubule dynamics and axodendritic architecture.\",\n      \"evidence\": \"Affinity purification, in vivo phospho-site mapping, JNK1-/- cortex analysis, FRAP, and neurite assays\",\n      \"pmids\": [\"16618812\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Contribution relative to other stathmin-family regulators not quantified\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"JNK1 was shown to physically engage and phosphorylate SIRT1 under oxidative stress, enhancing its nuclear localization and substrate-selective deacetylase activity.\",\n      \"evidence\": \"Endogenous Co-IP, in vitro kinase with site mapping, nuclear fractionation, and deacetylase assays\",\n      \"pmids\": [\"20027304\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Basis for SIRT1 substrate switching (H3 vs p53) not mechanistically defined\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Tissue-specific and isoform-specific knockouts revealed opposing roles in liver: hepatic JNK1 protects against steatosis while driving lipoapoptosis via PUMA, and JNK2 restrains Bim/Bax-dependent injury.\",\n      \"evidence\": \"Hepatocyte-specific and global Jnk knockouts, ChIP/EMSA, antisense knockdown, and metabolic readouts\",\n      \"pmids\": [\"19945406\", \"19638343\", \"19053047\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Reconciliation of protective vs proapoptotic hepatic JNK1 roles incomplete\", \"Cell-type origin of opposing effects not fully delineated\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Reciprocal regulation between JNK and APC/C(Cdh1) was established: APC/C degrades nuclear JNK during mitotic exit while JNK phosphorylates Cdh1 to attenuate APC/C in G2/M, integrating JNK into cell-cycle control.\",\n      \"evidence\": \"Co-IP, fractionation, in vitro kinase, non-degradable JNK mutant, and synchronization assays\",\n      \"pmids\": [\"20581839\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cell-cycle phenotype of preventing JNK degradation not fully characterized\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Jnk1 knockout established a role in hemostasis, with JNK1 required for platelet secretion, integrin activation, and thrombus formation via PKC.\",\n      \"evidence\": \"Jnk1-/- platelets, aggregation/secretion assays, bleeding time, and in vivo thrombosis models\",\n      \"pmids\": [\"20231429\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Platelet JNK1 substrates driving secretion not identified\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"JNK was placed in autophagy regulation downstream of TRAF2/RIPK1, mediating Bcl-xL degradation and BCL2L1-BECN1 dissolution to enable cytoprotective autophagy.\",\n      \"evidence\": \"siRNA of TRAF2/RIPK1/BECN1/ATG7 with autophagy and apoptosis readouts in cancer lines\",\n      \"pmids\": [\"23051914\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct JNK phosphorylation event triggering Bcl-xL degradation not mapped\", \"Single-lab pathway ordering\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Phosphorylation of Hes-1 at Ser263 defined a transcriptional mechanism by which JNK1 represses GluR1 and dampens AMPA-evoked calcium signaling in neurons.\",\n      \"evidence\": \"In vitro kinase, Ser263 mutagenesis, promoter reporter, ChIP, and calcium imaging\",\n      \"pmids\": [\"22302822\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological context driving this pathway in vivo not established\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"JNK1 was shown to suppress antifungal immunity by limiting NFATc1-driven CD23 expression and CD23-dependent nitric oxide production.\",\n      \"evidence\": \"Jnk1-/- mice, bone marrow chimeras, CD23 promoter reporters, and NO measurement\",\n      \"pmids\": [\"28112734\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct JNK1 substrate controlling NFATc1-CD23 axis not identified\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Mammary-specific JNK deletion defined JNK as a tumor suppressor acting through genome stability to prevent tumor initiation rather than restrain established growth.\",\n      \"evidence\": \"Mammary epithelium-specific JNK knockout mice with genomic instability and tumor incidence assays\",\n      \"pmids\": [\"29856313\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular substrates linking JNK to genome stability not defined\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"JNK1/2 phosphorylation of BNIP3 at Ser60/Thr66 was shown to stabilize BNIP3 and promote LC3-dependent mitophagy under hypoxia, with PP1/2A reversing the modification.\",\n      \"evidence\": \"In vitro kinase, site mutagenesis, BNIP3-LC3 Co-IP, proteasome inhibition, and mitophagy assays\",\n      \"pmids\": [\"36396625\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of JNK1 vs JNK2 not separated\", \"Single-lab study\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"USP14 was identified as a deubiquitinase that binds and stabilizes JNK protein, sustaining pathway output.\",\n      \"evidence\": \"Co-IP, knockdown/knockout in vitro and in vivo, and ubiquitination Western blots\",\n      \"pmids\": [\"36693850\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct deubiquitination of JNK not biochemically reconstituted\", \"Specific ubiquitin chain/site removed not defined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How JNK1 isoform- and tissue-specific outputs are encoded — the rules selecting among apoptotic, autophagic, cytoskeletal, transcriptional, and tumor-suppressive substrates in a given context — remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unifying model linking scaffold/upstream input to substrate choice\", \"Distinct JNK1 vs JNK2 substrate repertoires incompletely defined\", \"Spatial control of JNK substrate pools not systematically mapped\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [1, 2, 3, 4, 6, 7, 8, 17, 24]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [1, 3, 4, 6, 7, 17, 24]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [7, 24]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [8, 11]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [1, 2, 5, 9, 10, 27]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [4, 13, 14, 16]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [17, 22, 23]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [8]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [12, 20]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [11, 14, 24]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"MKK4\", \"MKK7\", \"GSTp\", \"RACK1\", \"SIRT1\", \"Cdh1\", \"USP14\", \"BNIP3\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}